Biology of Nicotinamide Coenzymes

Zheng-Hong Qin, MD; PhD Institute of Heath Technology, Suzhou Gaobo Vocational College, Qingshan Road, Suzhou Science and Technology Tower, Hi-Tech Area, Suzhou, China. He is the director of Institute of Heath Technology, Global Institute of Software technology. He has published more than 250 research papers and edited books Autophagy: Biology and Disease and Cobra Venom-Basic Research and Clinic Applications. He also contributed to 10 other books as an author. 

Chapter 1 Overview of nicotinamide coenzymes.- Chapter 2 Niacin deficiency and discovery of Vitamin B3 as a precursor of the nicotinamide coenzymes.- Chapter 3 Identification, source and intracellular distribution of nicotinamide coenzyme I.- Chapter 4 Overview of nicotinamide adenine dinucleotide.- Chapter 5.- The synthesis and degradation of NAD+ and methods for enhancing NAD+ levels.- Chapter 6 The role of nicotinamide phosphoribosyl transferase in NAD+ synthesis.- Chapter 7 Methods for coenzyme I assessment.- Chapter 8 Sources and cellular distribution of coenzyme II.- Chapter 9 Physiological functions of nicotinamide coenzyme II.- Chapter 10 Anabolism and catabolism of coenzyme II.- Chapter 11 Methods for increasing coenzyme II.- Chapter 12 The function of TIGAR and the synthesis of coenzyme II.- Chapter 13 The role of glucose 6-phosphate dehydrogenase in generating coenzyme II.- Chapter 14 Methods for coenzyme II assessment.- Chapter 15 Interconversion of coenzyme I and II, trans-organelle transport and its significance.- Chapter 16 Physiological role of nicotinamide coenzyme I in cellular metabolism.- Chapter 17 Nicotinamide adenine dinucleotide and signaling transduction.- Chapter 18 Nicotinamide adenine dinucleotide and immunoregulation.- Chapter 19 Coenzyme I and biological rhythm.- Chapter 20 Nicotinamide coenzyme II and free radical metabolism and homeostasis.- Chapter 21 Nicotinamide coenzyme II and reductive synthesis, biotransformation, and protein interactions.- Chapter 22 NADPH and purinergic signal transduction.- Chapter 23 Nicotinamide adenine dinucleotide and heart disease.-Chapter 24 Nicotinamide adenine dinucleotide in lipid metabolism and atherosclerosis.- Chapter 25 Nicotinamide adenine dinucleotide and ischemic stroke.- Chapter 26 Nicotinamide adenine dinucleotide and its precursors in hemorrhagic stroke.-Chapter 27 Nicotinamide coenzymes and metabolic diseases.- Chapter 28 Nicotinamide adenine dinucleotide and Aging.-Chapter 29 Coenzyme I and intestinal diseases.-Chapter 30 Coenzyme I and skeletal muscle disorders.- Chapter 31 Coenzyme I and chronic fatigue syndrome.- Chapter 32 Coenzyme I and depression.- Chapter 33 The role of NAD+-dependent signal mechanisms in cancer development and treatment.- Chapter 34 Nicotinamide adenine dinucleotide and Alzheimer disease.- Chapter 35 Nicotinamide adenine dinucleotide and Parkinson disease.- Chapter 36 Coenzyme II and aging.- Chapter 37 Coenzyme II and heart disease.- Chapter 38 Coenzyme II and vascular endothelium and blood-brain barrier.- Chapter 39 NADPH and Alzheimer's disease and Parkinson disease.-Chapter 40 Coenzyme II and ischemic stroke.- Chapter 41 NADPH and neuroinflammation.- Chapter 42 Nicotinamide coenzyme II and neuroexcitotoxicity.- Chapter 43 Inhibition of platelet aggregation and thrombosis by nicotinamide coenzymes.- Chapter 44 Research on the production technology of nicotinamide coenzymes and their precursors.- Chapter 45 Methods for industrial scale preparation and purification of nicotinamide coenzymes and their precursors.- Chapter 46 The application of the nicotinamide coenzymes and precursors.- Chapter 47 The application of nicotinamide coenzyme precursors in health food.- Chapter 48 Coenzyme I Drug.